Franchise Capital’s Eli Lilly LLY Stock Holding History

Franchise Capital’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-4,585	Closed	-$4.06M	–	17
2024 Q3	$4.06M	Buy	+4,585	New	+$4.12M	1.46%	9

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Franchise Capital's LLY Position: Q4 2024 in Review

Franchise Capital sold out of Eli Lilly (LLY) in Q4 2024, closing a stake of 4,585 shares — an estimated $4.06M sold.

Franchise Capital first reported a position in LLY in Q3 2024 and held it in 1 quarter. The position peaked at $4.06M in Q3 2024. 3,913 funds tracked by Wall St. Rank hold LLY as of Q4 2024.

Franchise Capital reported no remaining Eli Lilly position as of Q4 2024 after selling out during the quarter.
Franchise Capital sold 4,585 Eli Lilly shares in Q4 2024, an estimated $4.06M.
Franchise Capital first reported a position in Eli Lilly in Q3 2024 and held it in 1 quarter.
Franchise Capital's Eli Lilly position peaked at $4.06M in Q3 2024.
3,913 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2024.

Based on Franchise Capital's 13F filing for Q4 2024, filed 3 Jan 2025.